HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colgate-Palmolive restructuring

This article was originally published in The Rose Sheet

Executive Summary

Company states that it is on schedule with its restructuring program announced in 1991 ("The Rose Sheet" Sept. 16, 1991, p. 1). As of the end of 1993, Colgate had closed 11 factories and reconfigured 13; the firm said in 1991 that 25 plants would be affected. Consolidations achieved to date include production of all soap for the U.S. and Canada at one location, manufacture of toothpaste at three sites in Western Europe and production of Colgate Total toothpaste for Southern Africa at one central facility, the company notes in its recently released annual report. Colgate has eliminated over 2,000 positions worldwide so far; when it announced the restructuring, the company estimated it would cut 2,000 posts. Savings from the restructuring are being used for research and development, advertising, new product launches, geographic expansion, acquisitions and dividends

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel